Sign in

CIK 0001427570

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Vyome Holdings, Inc

Sign in to watch
Ticker
HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-429-6680
Business address
1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
Former names
ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 1 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-29 VandenBerg Amy VP of Reg. and Clin. Affairs Option exercise +1,541 $1.31 $2K 6,650
2018-01-29 VandenBerg Amy VP of Reg. and Clin. Affairs Option exercise · Employee Stock Option (right to buy) −4,022 0
2018-01-29 VandenBerg Amy VP of Reg. and Clin. Affairs Option exercise · Employee Stock Option (right to buy) −1,087 0
2018-01-29 VandenBerg Amy VP of Reg. and Clin. Affairs Option exercise · Employee Stock Option (right to buy) −1,541 0
2018-01-02 Metzner Lisa VP of Marketing Grant or award · Stock Option (Right to Buy) +60,000 60,000
2018-01-02 Rasdal Andrew P President & CEO Grant or award · Stock Option (Right to Buy) +300,000 300,000
2018-01-02 Norwood Matthew VP of Sales Grant or award · Stock Option (Right to Buy) +50,000 50,000
2018-01-02 Young Donald R VP of Quality Assurance Grant or award · Stock Option (Right to Buy) +50,000 50,000
2018-01-02 Hussainy Nooshin VP of Finance Grant or award · Stock Option (Right to Buy) +50,000 50,000
2018-01-02 Plovanic William J. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2018-01-02 Huang Kelly Chief Operating Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2018-01-02 Drake Neil VP Research and Development Grant or award · Stock Option (Right to Buy) +35,000 35,000
2018-01-02 Brister Mark Chief Technology Officer Grant or award +65,000 65,000
2018-01-02 VandenBerg Amy VP of Reg. and Clin. Affairs Grant or award +60,000 60,000
2017-10-31 Hussainy Nooshin VP of Finance Grant or award +502 $7.17 $4K 58,545
2017-10-31 Rasdal Andrew P President & CEO Grant or award +808 $7.17 $6K 454,071
2017-10-31 Johnson Steven Ernest VP of Operations Grant or award +942 $7.17 $7K 1,689
2017-10-31 Drake Neil VP Research and Development Grant or award +1,743 $7.17 $12K 7,924
2017-10-31 Brister Mark Chief Technology Officer Grant or award +1,860 $7.17 $13K 163,870
2017-09-06 Huang Kelly Chief Operating Officer Grant or award · Stock Option (Right to Buy) +269,230 269,230

Page 13 of 17 · 322 trades